DOI QR코드

DOI QR Code

Polypharmacy and Potentially Inappropriate Medication Use in Elderly Patients Hospitalized after Falls

낙상으로 입원한 노인의 다약제복용과 잠재적 부적절 약물 사용

  • Kim, Ji-Yeon (Hanmaeum Hospital) ;
  • Choi, Suyoung (College of Nursing, Health and Nursing Research Institute, Jeju National University)
  • 김지연 (한마음병원) ;
  • 최수영 (제주대학교 간호대학.건강과간호연구소)
  • Received : 2022.05.02
  • Accepted : 2022.08.09
  • Published : 2022.08.31

Abstract

Purpose: The purpose of this study was to investigate polypharmacy and potentially inappropriate medication (PIM) use in elderly patients admitted to hospitals after falls. Methods: The study surveyed 283 patients 65 or older admitted January 1-December 31, 2016. Data were collected from electronic medical records, and medications administered immediately prior to admission were examined. PIM use for patients was investigated using the Beers criteria, and data were analyzed by Chi-square test and independent ttest. Results: The average age of participants was 79.42± 8.16, and the study included 226 women (79.9%) and 57 men (20.1%). The average number of self-administered medications daily was 4.94± 3.68, and 55.1% took five or more medications. PIM use was found in 107 patients (37.8%). There was a significant difference in polypharmacy according to age, and the proportion of medical aid beneficiaries and prevalence of cardiocerebrovascular, endocrine, and other chronic diseases were higher in the polypharmacy and PIM use patients than in the non-polypharmacy and non-PIM use patients. The number of chronic diseases and medications taken were significantly high among polypharmacy and PIM use patients. Conclusion: It is necessary to minimize polypharmacy and PIM use, and establish a system for systematically evaluating and managing medication use to prevent falls in the elderly.

Keywords

References

  1. Baek JY, Lee E, Jung HW, Jang IY. Geriatrics fact sheet in Korea 2021. Annals of Geriatric Medicine and Research. 2021;25(2):65-71. https://doi.org/10.4235/agmr.21.0063
  2. Cheong SJ, Yoon JL, Choi SH, Kim MY, Cho JJ, Ju YS. The effect of polypharmacy on mortality in the elderly. Korean Journal of Family Practice. 2016;6(6):643-650. https://doi.org/10.21215/kjfp.2016.6.6.643
  3. Korean Society for Pharmacoepidemiology and Risk Management. Pharmacodynamics. Seoul: Seoul National University Publishing & Cultural Center; 2012.
  4. Park HY, Sohn HS, Kwon JW. Reviews on the current status and appropriate management of polypharmacy in South Korea. Korean Journal of Clinical Pharmacy. 2018;28(1):1-9. https://doi.org/10.24304/kjcp.2018.28.1.1
  5. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2012;67(6):698-704. https://doi.org/10.1093/gerona/glr233
  6. Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2015;70(8):989-995. https://doi.org/10.1093/gerona/glv013
  7. Bhagavathula AS, Gebreyohannes EA, Fialova D. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country: a systematic review and meta-analysis. Gerontology. 2022;68:136-145. https://doi.org/10.1159/000516075
  8. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2015;63(11):2227-2246. https://doi.org/10.1111/jgs.13702
  9. Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5(12):e009235. https://doi.org/10.1136/bmjopen-2015-009235
  10. Nam YS, Han JS, Kim JY, Bae WK, Lee K. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a crosssectional population based study. BMC Geriatrics. 2016;16(1):1-9. https://doi.org/10.1186/s12877-016-0285-3
  11. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clinics in Geriatric Medicine. 2012;28(2):173-186. https://doi.org/10.1016/j.cger.2012.01.002
  12. Fried TR, O'Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. Journal of the American Geriatrics Society. 2014;62(12):2261-2272. https://doi.org/10.1111/jgs.13153
  13. Freeland KN, Thompson AN, Zhao Y, Leal JE, Mauldin PD, Moran WP. Medication use and associated risk of falling in a geriatric outpatient population. Annals of Pharmacotherapy. 2012;46(9):1188-1192. https://doi.org/10.1345/aph.1Q689
  14. Kojima T, Akishita M, Nakamura T, Nomura K, Ogawa S, Iijima K, et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatrics & Gerontology International. 2011;11(4):438-444. https://doi.org/10.1111/j.1447-0594.2011.00703.x
  15. Hammond T, Wilson A. Polypharmacy and falls in the elderly: a literature review. Nursing and Midwifery Studies. 2013;2(2):171-175. https://doi.org/10.5812/nms.10709
  16. Karlsson MK, Magnusson H, von Schewelov T, Rosengren BE. Prevention of falls in the elderly: a review. Osteoporosis International. 2013;24(3):747-762. https://doi.org/10.1007/s00198-012-2256-7
  17. Seo DS, Yoon JL, Kim SJ, Park JS, Lee WJ, Kim MY. Polypharmacy in older patients admitted to a general hospital. Journal of the Korean Geriatrics Society. 2012;16(3):133-140. https://doi.org/10.4235/jkgs.2012.16.3.133
  18. Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs & Aging. 2014;31(3):225-232. https://doi.org/10.1007/s40266-013-0151-3
  19. Lim JO, Gu MO. Fall-related circumstances and fall risk factors among inpatients with dementia in long-term care hospital. Journal of Korean Gerontologcial Nursing. 2016;18(2):72-83. https://doi.org/10.17079/jkgn.2016.18.2.72
  20. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine. 2010;89(5):295-299. https://doi.org/10.1097/MD.0b013e3181f15efc
  21. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. British Journal of Clinical Pharmacology. 2006;61(2):218-223. https://doi.org/10.1111/j.1365-2125.2005.02543.x
  22. Lee JK. Factors associated with drug misuse behaviors among polypharmacy elderly. Korean Journal of Adult Nursing. 2011;23(6):554-563.
  23. Lee YJ. Medication use as a risk factor for falls in hospitalized elderly patients in Korea. Korean Journal of Clinical Pharmacy. 2011;21(3):243-248.
  24. Park YI, Lee KY, Kim DO, Uhm DC, Kim JH. Medication status and the effects of a medication management education program for the elderly in a community. Journal of Korean Academy of Community Health Nursing. 2014;25(3):170-179. https://doi.org/10.12799/jkachn.2014.25.3.170
  25. Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly. Drugs & Aging. 2012;29(5):359-376. https://doi.org/10.2165/11599460-000000000-00000
  26. Fraser L, Leslie W, Targownik L, Papaioannou A, Adachi J. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporosis International. 2013;24(4):1161-1168. https://doi.org/10.1007/s00198-012-2112-9
  27. Lee YW, Nam SI. Medications as risk factor for falls. Research in Vestibular Science. 2016;14(4):101-106. https://doi.org/10.21790/rvs.2016.15.4.101
  28. Park JY, Jun K, Baek YS, Park SY, JY L. Medication use review tools for community dwelling older patients: a systematic review. Korean Journal of Clinical Pharmacy. 2021;31(1):61-78. https://doi.org/10.24304/kjcp.2021.31.1.61
  29. Park HY, Ryu HN, Shim MK, Sohn HS, Kwon JW. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data. International Journal of Clinical Pharmacology and Therapeutics. 2016;54(5):369-377. https://doi.org/10.5414/CP202484
  30. Bae MK, Lee IH, Yoon JH. Assessment of potentially inappropriate medication use in Korean elderly patients with chronic heart failure. Korean Journal of Clinical Pharmacy. 2014;24(2):115-125.
  31. Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PloS One. 2014;9(6):e98043. https://doi.org/10.1371/journal.pone.0098043
  32. Levy HB. Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria. Clinics in Geriatric Medicine. 2017;33(2):177-187. https://doi.org/10.1016/j.cger.2017.01.007
  33. San-Jose A, Agusti A, Vidal X, Formiga F, Gomez-Hernandez M, Garcia J, et al. Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatrics. 2015;15(1):1-9. https://doi.org/10.1186/s12877-015-0038-8